Morphine promising treatment to palliate cough in IPF patients: PACIFY COUGH study Medha Baranwal22 Jan 2024 5:00 PM ISTUK: Findings from the PACIFY COUGH study published in The Lancet Respiratory Medicine have shown morphine to be promising as an effective treatment to...
Aviptadil fails to improve clinical outcomes in COVID-19 patients with acute hypoxaemic respiratory failure: Lancet Medha Baranwal23 Jun 2023 11:30 AM ISTUSA: Intravenous aviptadil failed to improve clinical outcomes up to day 90 among patients with COVID-19-associated acute hypoxaemic respiratory...
Does treatment of inoperable chronic thromboembolic pulmonary hypertension require multimodality approach? Medha Baranwal13 Aug 2022 10:15 AM ISTFrance: Balloon pulmonary angioplasty (BPA) and riociguat are treatment options for inoperable chronic thromboembolic pulmonary hypertension (CTEPH)....
Endoscopic surgery, medicine combo effective for chronic sinusitis with nasal polyps: Lancet Medha Baranwal11 April 2022 8:15 PM ISTNetherlands: Endoscopic sinus surgery (ESS) plus medical therapy is more effective than medical therapy alone in chronic rhinosinusitis with nasal...
Prophylactic CPAP may not reduce risk of pneumonia or reintubation after Surgery MD Editorial Team31 Aug 2021 9:00 AM ISTIn the Lancet study conducted by contributors at PRISM Trial Group, it was found out that the routine use of prophylactic postoperative continuous...
Colchicine beneficial in COVID-19 RTCPR confirmed cases, Lancet study dr. Abhimanyu Uppal2 Jun 2021 9:00 AM ISTEvidence suggests a role for excessive inflammation in COVID-19 complications. Colchicine, an oral anti-inflammatory medication is hypothesized to...
Colchicine effective option for non-hospitalized COVID-19 patients at risk of complications: Lancet Dr Kartikeya Kohli29 May 2021 8:45 AM ISTResearchers at Montreal Health Innovation Coordinating Centre (MHICC) have found in a phase 3, randomised, double-blinded, adaptive,...
Peginterferon lambda accelerates viral decline in outpatients with COVID-19: LANCET Dr. Nandita Mohan19 May 2021 9:00 AM ISTRecent research published in the Lancet- Respiratory Medicine Journal revealed that peginterferon lambda is among the first antiviral therapies to...
Patients with COPD at Increased Risk of Cognitive Impairment MD Bureau31 Dec 2020 4:45 PM ISTCOPD is associated with a series of comorbidities, including ischemic heart disease, hypertension, diabetes, lung cancer, and so on. In addition, a...
Reduced HDL cholesterol tied to prolonged COVID-19 virus clearance time: Study Dr Satabdi Saha11 Nov 2020 3:29 PM ISTAccording to the reports of a recently published study, ALT, GLU and HDLC were independent factors that influenced the clearance time of SARS Cov 2...
Fact Check: Controversy surrounding Ace inhibitors and Coronavirus Hina Zahid19 March 2020 11:15 AM ISTA controversy was recently created due to correspondence in Lancet Respiratory Medicine, that ACE-inhibitors and ARBs may increase the risk for...
New drug Gefapixant effectively relieves chronic cough: Lancet Dr. Kamal Kant Kohli26 Feb 2020 7:00 PM ISTResearchers have found a new drug that can ease the often distressing symptoms of chronic cough at low doses with minimal side effects. The new...
